Improving adherence to cardiovascular disease medications with information technology

William M. Vollmer, Ashil A. Owen-Smith, Jeffrey O. Tom, Reesa Laws, Diane G. Ditmer, David H. Smith, Amy C. Waterbury, Jennifer L. Schneider, Cyndee H. Yonehara, Andrew Williams, Suma Vupputuri, Cynthia S. Rand

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


OBJECTIVES: Evaluate the utility of 2 electronic medical record (EMR)-linked, automated phone reminder interventions for improving adherence to cardiovascular disease medications.

STUDY DESIGN: A 1-year, parallel arm, pragmatic clinical trial in which 21,752 adults were randomized to receive either usual care (UC) or 1 of 2 interventions in the form of interactive voice recognition calls-regular (IVR) or enhanced (IVR+). The interventions used automated phone reminders to increase adherence to cardiovascular disease medications. The primary outcome was medication adherence; blood pressure and lipid levels were secondary outcomes.

METHODS: The study took place in 3 large health maintenance organizations. We enrolled participants who were 40 years or older, had diabetes mellitus or atherosclerotic cardiovascular disease, and were suboptimally adherent. IVR participants received automated phone calls when they were due or overdue for a refill. IVR+ participants received these phone calls, plus personalized reminder letters, live outreach calls, EMR-based feedback to their primary care providers, and additional mailed materials.

RESULTS: Both interventions significantly increased adherence to statins and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs) compared with UC (1.6 to 3.7 percentage points). Adherence to ACEIs/ARBs was also significantly higher for IVR+ relative to IVR participants. These differences persisted across subgroups. Among statin users, IVR+ participants had significantly lower low-density lipoprotein (LDL) levels at follow-up compared with UC (Δ = -1.5; 95% CI, -2.7 to -0.2 mg/dL); this effect was seen mainly in those with baseline LDL levels ≥ 100 mg/dL (Δ = -3.6; 95% CI, -5.9 to -1.3 mg/dL).

CONCLUSIONS: Technology-based tools, in conjunction with an EMR, can improve adherence to chronic disease medications and measured cardiovascular disease risk factors.

Original languageEnglish (US)
Pages (from-to)SP502-SP510
JournalThe American journal of managed care
Issue number17
StatePublished - Nov 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Improving adherence to cardiovascular disease medications with information technology'. Together they form a unique fingerprint.

Cite this